Shin Poong Pharm Co.,Ltd. (South Korea)

Shin Poong Pharm Co., Ltd. is a pharmaceutical company located in Ansan. Since its foundation, the company has been dedicated to improving national health and the health of mankind. They focus on independent technology development and export diversification, ranging from active pharmaceutical ingredients to finished drugs. In the 70s and 80s, Shin Poong Pharm successfully synthesized the raw materials of mebendazole and praziquantel, which contributed to the eradication of parasites and dystosides. In the 90s, the company established overseas subsidiaries in China, Vietnam, and Sudan, expanding its presence in the global market through pharmaceutical exports. In the 2000s, Shin Poong Pharm collaborated with WHO and MMV to develop a new antimalarial drug called 'Piramax' and conducted research on innovative new drugs. Their ability to develop new drugs has been recognized both domestically and internationally, and they continue to strive for the development of innovative and improved drugs based on their R&D technology. Shin Poong Pharm is committed to producing and supplying high-quality medicines using state-of-the-art production facilities. They have fully automated all formulations from raw materials to finished products, ensuring the production of excellent medicines. The company also focuses on creating high-value-added new drugs and developing technologies through their Central Research Institute for the creation of new substances. In the future, Shin Poong Pharm aims to maintain its competitiveness through research and development for human health and a prosperous life. They strive to be a trusted company by customers and contribute to the promotion of human welfare. The company's employees are dedicated to creating new hope and establishing Shin Poong Pharm as a global leader in the pharmaceutical industry.